Browse products alphabetically or search by name.
Active Ingredient: Ibrutinib
Unit: 30 | Pack: Tablet
USD $354.00
Unit: 120 | Pack: Tablet
USD $6840.00
Health Guides
Apr 24, 2026
Ibrutinib is an oral targeted cancer medicine, sold under the brand name Imbruvica, that blocks Bruton's tyrosine kinase, or BTK. BTK helps certain B-cells grow and survive, so blocking it can slow or stop some blood cancers, including chronic lymphocytic leukemia, small lymphocytic lymphoma, and Wa
